Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healios KK Ord Shs HLOSF

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.


PINL:HLOSF - Post by User

Post by ama21968on Oct 13, 2010 9:19pm
295 Views
Post# 17561864

Who are they?

Who are they?HALO RESOURCES LTD. ("HLO")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: October 13, 2010
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing documentation with respect
to the second and final tranche of a Non-Brokered Private Placement
originally announced September 29, 2010 and amended on October 1, 2010:

Number of Shares:            800,000 shares

Purchase Price:             
.25 per share

Warrants:                    800,000 share purchase warrants to purchase
                             800,000 shares

Warrant Exercise Price:     
.35 for a two year period

Number of Placees:           11 placees

Insider / Pro Group Participation:

                             Insider=Y /
Name                        ProGroup=P /        # of Shares
Bryan Paul                           P               40,000
Kelly Klatik                           P               30,000

Finder's Fee:     $2,800 and 11,200 share purchase warrants
                             payable to Northern Securities Inc.
                             $1,800 payable to Michael Drolet
                             $2,600 and 10,400 share purchase warrants
                             payable to All Group Financial Services

Pursuant to Corporate Finance Policy 4.1, Section 1.11(d), the Company
must issue a news release announcing the closing of the private placement
and setting out the expiry dates of the hold period(s). The Company must
also issue a news release if the private placement does not close
promptly. (Note that in certain circumstances the Exchange may later
extend the expiry date of the warrants, if they are less than the maximum
permitted term.)

<< Previous
Bullboard Posts
Next >>